Evidence map›Paper›PMID 17171495›Full record

ArticleWorld journal of surgery2007

Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.

Qi-Lu Qiao, Yi-Guo Zhao, Mu-Lin Ye, Yin-Mo Yang, Jian-Xun Zhao, Yan-Ting Huang, Yuan-Lian Wan

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Review of the investigation and surgical management of resectable ampullary adenocarcinoma.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2013
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Expression Profile of KRAS and p16 in Periampullary Cancer.Indian journal of surgical oncology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Treatment Approach to Adenocarcinoma of the Ampulla of Vater.Current treatment options in oncology · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2018
    Article
  19. Endoscopic papillectomy of benign ampullary lesions: Outcomes from a multicenter study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qi-Lu QiaoDepartment of Surgery, First Hospital, Peking University, Beijing, 100034, China. qilugiao@hotmail.com
Yi-Guo Zhao
Mu-Lin Ye
Yin-Mo Yang
Jian-Xun Zhao
Yan-Ting Huang
Yuan-Lian Wan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe prognosis for patients with carcinoma of the ampulla of Vater is improved relative to other periampullary neoplasms. Identification of independent prognostic factors in ampullary carcinomas has been limited by the small number of tumors resected. The aim of the present study was to determine the clinicopathologic factors that influence long-term survival in patients with resected ampullary carcinoma.

methodsClinicopathologic data were retrospectively reviewed for patients with ampullary carcinomas radically resected between March 1987 and September 2002. The correlation between clinicopathologic variables and survival of patients after resection was examined by the Kaplan-Meier method, the log-rank test, and Cox proportional hazards regression. Ampullary carcinomas were radically resected in 127 patients either by pancreaticoduodenectomy (n = 124) or local resection (n = 3).

resultsHospital mortality was 9.7%. The overall actuarial survival rates (including hospital deaths) at 1, 3, 5, and 10 years were 76.2%, 46.8%, 43.3%, and 35.7%, respectively. Factors that significantly influenced survival were lymph node status (P < 0.001), depth of tumor infiltration (P = 0.029), and TNM stage (P < 0.001) on univariate analysis. On multivariate analysis, both depth of infiltration and lymph node status were the independent determinants of survival after resection (P = 0.003, P = 0.005, respectively).

conclusionsCarcinoma of the ampulla of Vater has a higher resectability rate and a much better survival rate than pancreatic cancer. Pancreaticoduodenectomy is the treatment of choice for this tumor. Long-term survival was independently influenced by the depth of tumor infiltration and lymph node metastasis.

Indexed as

Ampulla of VaterPancreaticoduodenectomyAdenocarcinomaAdolescentAdultAgedCommon Bile Duct NeoplasmsFemaleHospital MortalityHumansLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessProportional Hazards ModelsRetrospective Studies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.